Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Uterine Cervical Neoplasms 10 Neoplasms 9 Breast Neoplasms 9 Colorectal Neoplasms 8 Lung Neoplasms 5 Papillomavirus Infections 3 Uterine Cervical Dysplasia 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Heart Diseases 2 HIV Infections 2 Gastrointestinal Neoplasms 2 Esophageal Neoplasms 2 End Stage Liver Disease 2 the Rate of Participation in Screening for PBC 1 Warts 1 Venous Thromboembolism 1 Uterine Cervical Diseases 1 Urinary Bladder Neoplasms 1 Tinea 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Skin Neoplasms 1 Retinoblastoma 1 Radiation Injuries 1 Pulmonary Atelectasis 1 Postural Orthostatic Tachycardia Syndrome 1 Postoperative Complications 1

Interventions

Sirolimus 4 LY3295668 erbumine 3 Everolimus 3 Medical Marijuana 2 Anticonvulsants 2 ziprasidone 1 perampanel 1 enzalutamide 1 clevidipine 1 brivaracetam 1 Zolpidem 1 Warfarin 1 Vigabatrin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Topotecan 1 Tobramycin 1 Therapeutic Touch 1 Temozolomide 1 TAS-119 1 Surgical Procedures, Operative 1 Sulfasalazine 1 Spironolactone 1 Sevoflurane 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Registries 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Epilepsy × Mass Screening × Clear all

NCT00152659 2023-04-26

Developing Criteria for Cortical Resections

University of Chicago

Epilepsy, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡